Resolvin D1 reduces cancer growth stimulating a protective neutrophil-dependent recruitment of anti-tumor monocytes

BACKGROUND: Innovative therapies to target tumor-associated neutrophils (PMN) are of clinical interest, since these cells are centrally involved in cancer inflammation and tumor progression. Resolvin D1 (RvD1) is a lipid autacoid that promotes resolution of inflammation by regulating the activity of...

Descripción completa

Detalles Bibliográficos
Autores principales: Mattoscio, Domenico, Isopi, Elisa, Lamolinara, Alessia, Patruno, Sara, Medda, Alessandro, De Cecco, Federica, Chiocca, Susanna, Iezzi, Manuela, Romano, Mario, Recchiuti, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8040222/
https://www.ncbi.nlm.nih.gov/pubmed/33845864
http://dx.doi.org/10.1186/s13046-021-01937-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8040222/
https://www.ncbi.nlm.nih.gov/pubmed/33845864
http://dx.doi.org/10.1186/s13046-021-01937-3

Ejemplares similares